论文部分内容阅读
目的观察糖尿病患者围手术期使用胰岛素泵持续皮下注射(CSII)的有效性和安全性。方法将需要手术的糖尿病患者80例,随机分为胰岛素泵组和诺和锐30三针组,分别观察两组患者的治疗后血糖、血糖达标时间、胰岛素用量、低血糖发生情况及切口愈合情况。结果两组均能使血糖达标,CSII组血糖达标时间更短、胰岛素用量更少、发生低血糖少,切口愈合更好。结论胰岛素泵应用于糖尿病围手术期疗效及安全性均较好,是较好的治疗方法。
Objective To observe the efficacy and safety of continuous subcutaneous injection (CSII) of insulin pump during perioperative period in diabetic patients. Methods Eighty diabetic patients undergoing surgery were randomly divided into insulin pump group and Nuo Rui Rui 30 three-needle group. The blood glucose, blood glucose compliance time, insulin dosage, hypoglycemia and wound healing of the two groups were observed respectively . Results The blood sugar level was achieved in both groups. The CSII group had shorter blood glucose compliance time, less insulin dosage, less hypoglycemia and better incision healing. Conclusion The application of insulin pump in perioperative diabetes mellitus is safe and effective. It is a good treatment.